| |
| |
|
| Insider
Information: |
Sirgo Mark A |
| Relationship: |
Director |
| City: |
Raleigh |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
1,587,828 |
|
|
Indirect Shares
|
22,965 |
|
|
| Direct
Value |
$17,154 |
|
|
|
Indirect Value
|
$8,273 |
|
|
| Total
Shares |
1,610,793 |
|
|
| Total
Value |
$25,427 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
18
|
5
|
|
Stock
price went up :
|
11
|
1
|
| Stock
price went down : |
7
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
1.6
|
1.6
|
| Percentage
Gain/Loss : |
 21.7%
|
 -32.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biodelivery Sciences Internation... |
BDSI |
Director |
2022-03-22 |
0 |
2014-09-04 |
1,480 |
Premium* |
|
|
Salix Pharmaceuticals Ltd |
SLXP |
Director |
2015-04-01 |
0 |
2008-07-01 |
0 |
Premium* |
|
|
Biomerica Inc |
BMRA |
Director |
2020-04-21 |
27,400 |
2016-08-01 |
0 |
Premium* |
|
|
9 Meters Biopharma Inc |
NMTR |
Director |
2022-07-01 |
1,560,428 |
2022-07-01 |
21,485 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
182 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 7 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2009-02-02 |
4/A |
D |
$8.00 |
$12,400 |
D/D |
(1,550) |
26,126 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2009-02-02 |
4 |
D |
$8.00 |
$12,000 |
D/D |
(1,500) |
26,176 |
0 |
- |
|
| BMRA |
Biomerica Inc |
Director |
– • – |
2020-04-17 |
4 |
S |
$8.05 |
$40,346 |
D/D |
(5,000) |
13,700 |
0 |
% |
|
| BMRA |
Biomerica Inc |
Director |
– • – |
2020-04-21 |
4 |
S |
$8.11 |
$40,532 |
D/D |
(5,000) |
8,700 |
0 |
% |
|
| BDSI |
Biodelivery Sciences Inte... |
President and CEO |
• • – |
2014-03-19 |
4 |
A |
$8.88 |
$15,140 |
D/D |
1,705 |
914,955 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
President and CEO |
• • – |
2014-02-20 |
4 |
A |
$8.90 |
$1,246,000 |
D/D |
140,000 |
955,250 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
President and CEO |
• • – |
2014-02-20 |
4 |
AS |
$8.92 |
$374,640 |
D/D |
(42,000) |
913,250 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
President and CEO |
• • – |
2014-01-24 |
4 |
AS |
$9.01 |
$1,047,440 |
D/D |
(116,253) |
815,250 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2009-07-01 |
4 |
D |
$9.87 |
$38,789 |
D/D |
(3,930) |
23,196 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2009-05-08 |
4 |
B |
$10.34 |
$10,385 |
D/D |
1,000 |
27,126 |
2.39 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
President and CEO |
• • – |
2014-12-15 |
4 |
B |
$12.23 |
$30,575 |
D/D |
2,500 |
923,602 |
2.81 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2009-08-14 |
4 |
B |
$12.40 |
$11,840 |
D/D |
950 |
36,306 |
2.39 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
President and CEO |
• • – |
2015-02-25 |
4 |
AS |
$14.25 |
$1,339,500 |
D/D |
(94,000) |
1,062,637 |
0 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
President and CEO |
• • – |
2014-09-04 |
4 |
B |
$15.04 |
$30,080 |
D/D |
2,000 |
922,102 |
2.81 |
- |
|
| BDSI |
Biodelivery Sciences Inte... |
President and CEO |
• • – |
2014-09-04 |
4 |
B |
$15.90 |
$7,632 |
I/I |
480 |
1,480 |
2.58 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2010-01-15 |
4 |
B |
$27.09 |
$5,418 |
D/D |
200 |
36,706 |
2.39 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2010-01-06 |
4 |
B |
$27.89 |
$5,578 |
D/D |
200 |
36,506 |
2.39 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2010-02-04 |
4 |
D |
$29.26 |
$45,353 |
D/D |
(1,550) |
35,156 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2011-03-10 |
4 |
S |
$32.40 |
$54,270 |
D/D |
(1,675) |
34,071 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2011-05-27 |
4 |
S |
$38.93 |
$65,208 |
D/D |
(1,675) |
37,036 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2010-07-01 |
4 |
D |
$39.03 |
$147,143 |
D/D |
(3,770) |
31,386 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2011-07-01 |
4 |
D |
$39.83 |
$53,850 |
D/D |
(1,352) |
35,684 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2012-11-12 |
4 |
S |
$40.30 |
$69,518 |
D/D |
(1,725) |
36,680 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2012-11-13 |
4 |
S |
$40.75 |
$70,294 |
D/D |
(1,725) |
34,955 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2013-01-11 |
4 |
AS |
$46.19 |
$138,570 |
D/D |
(3,000) |
31,955 |
0 |
- |
|
182 Records found
|
|
Page 7 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
